Legend
Please note that a short description of a certain column can be displayed when you move your mouse cursor over the column's header and hold it still. Below, a more detailed description is shown per column.
ID_report: ID of the individual that can be publically shared, e.g. as listed in a publication
Reference: reference to publication describing the individual/family, possibly giving more phenotypic details than listed in this database entry, incl. link to PubMed or other source, e.g. "den Dunnen ASHG2003 P2346"
Remarks: remarks about the individual
Gender: gender individual
All options:
- ? = unknown
- - = not applicable
- F = female
- M = male
- rF = raised as female
- rM = raised as male
Consanguinity: indicates whether the parents are related (consanguineous), not related (non-consanguineous) or whether consanguinity is not known (unknown)
All options:
- no = non-consanguineous parents
- yes = consanguineous parents
- likely = consanguinity likely
- ? = unknown
- - = not applicable
Country: where (country) does the individual live/recently came from. Give additional details (population, specific sub-group) and when parents come from different countries in "Population". Belgium = individual lives in/recently came from Belgium, (France) = reported by laboratory in France, individual's country of origin not sure
All options:
- ? (unknown)
- - (not applicable)
- Afghanistan
- (Afghanistan)
- Albania
- (Albania)
- Algeria
- (Algeria)
- American Samoa
- (American Samoa)
- Andorra
- (Andorra)
- Angola
- (Angola)
- Anguilla
- (Anguilla)
- Antarctica
- (Antarctica)
- Antigua and Barbuda
- (Antigua and Barbuda)
- Argentina
- (Argentina)
- Armenia
- (Armenia)
- Aruba
- (Aruba)
- Australia
- (Australia)
- Austria
- (Austria)
- Azerbaijan
- (Azerbaijan)
- Bahamas
- (Bahamas)
- Bahrain
- (Bahrain)
- Bangladesh
- (Bangladesh)
- Barbados
- (Barbados)
- Belarus
- (Belarus)
- Belgium
- (Belgium)
- Belize
- (Belize)
- Benin
- (Benin)
- Bermuda
- (Bermuda)
- Bhutan
- (Bhutan)
- Bolivia
- (Bolivia)
- Bosnia and Herzegovina
- (Bosnia and Herzegovina)
- Botswana
- (Botswana)
- Bouvet Island
- (Bouvet Island)
- Brazil
- (Brazil)
- British Indian Ocean Territory
- (British Indian Ocean Territory)
- Brunei Darussalam
- (Brunei Darussalam)
- Bulgaria
- (Bulgaria)
- Burkina Faso
- (Burkina Faso)
- Burundi
- (Burundi)
- Cambodia
- (Cambodia)
- Cameroon
- (Cameroon)
- Canada
- (Canada)
- Cape Verde
- (Cape Verde)
- Cayman Islands
- (Cayman Islands)
- Central African Republic
- (Central African Republic)
- Central Europe
- Chad
- (Chad)
- Chile
- (Chile)
- China
- (China)
- Christmas Island
- (Christmas Island)
- Cocos (Keeling Islands)
- (Cocos (Keeling Islands))
- Colombia
- (Colombia)
- Comoros
- (Comoros)
- Congo
- (Congo)
- Cook Islands
- (Cook Islands)
- Costa Rica
- (Costa Rica)
- Cote D'Ivoire (Ivory Coast)
- (Cote D'Ivoire (Ivory Coast))
- Croatia (Hrvatska)
- (Croatia (Hrvatska))
- Cuba
- (Cuba)
- Cyprus
- (Cyprus)
- Czech Republic
- (Czech Republic)
- Denmark
- (Denmark)
- Djibouti
- (Djibouti)
- Dominica
- (Dominica)
- Dominican Republic
- (Dominican Republic)
- East Timor
- (East Timor)
- Ecuador
- (Ecuador)
- Egypt
- (Egypt)
- El Salvador
- (El Salvador)
- England
- (England)
- Equatorial Guinea
- (Equatorial Guinea)
- Eritrea
- (Eritrea)
- Estonia
- (Estonia)
- Ethiopia
- (Ethiopia)
- Falkland Islands (Malvinas)
- (Falkland Islands (Malvinas))
- Faroe Islands
- (Faroe Islands)
- Fiji
- (Fiji)
- Finland
- (Finland)
- France
- (France)
- Gabon
- (Gabon)
- Gambia
- (Gambia)
- Georgia
- (Georgia)
- Germany
- (Germany)
- Ghana
- (Ghana)
- Gibraltar
- (Gibraltar)
- Greece
- (Greece)
- Greenland
- (Greenland)
- Grenada
- (Grenada)
- Guadeloupe
- (Guadeloupe)
- Guam
- (Guam)
- Guatemala
- (Guatemala)
- Guiana, French
- (Guiana, French)
- Guinea
- (Guinea)
- Guinea-Bissau
- (Guinea-Bissau)
- Guyana
- (Guyana)
- Haiti
- (Haiti)
- Heard and McDonald Islands
- (Heard and McDonald Islands)
- Honduras
- (Honduras)
- Hong Kong
- (Hong Kong)
- Hungary
- (Hungary)
- Iceland
- (Iceland)
- India
- (India)
- Indonesia
- (Indonesia)
- Iran
- (Iran)
- Iraq
- (Iraq)
- Ireland
- (Ireland)
- Israel
- (Israel)
- Italy
- (Italy)
- Jamaica
- (Jamaica)
- Japan
- (Japan)
- Jordan
- (Jordan)
- Kazakhstan
- (Kazakhstan)
- Kenya
- (Kenya)
- Kiribati
- (Kiribati)
- Korea
- (Korea)
- Korea, North (People's Republic)
- (Korea, North (People's Republic))
- Korea, South (Republic)
- (Korea, South (Republic))
- Kosovo
- (Kosovo)
- Kuwait
- (Kuwait)
- Kyrgyzstan (Kyrgyz Republic)
- (Kyrgyzstan (Kyrgyz Republic))
- Laos
- (Laos)
- Latvia
- (Latvia)
- Lebanon
- (Lebanon)
- Lesotho
- (Lesotho)
- Liberia
- (Liberia)
- Libya
- (Libya)
- Liechtenstein
- (Liechtenstein)
- Lithuania
- (Lithuania)
- Luxembourg
- (Luxembourg)
- Macau
- (Macau)
- Macedonia
- (Macedonia)
- Madagascar
- (Madagascar)
- Malawi
- (Malawi)
- Malaysia
- (Malaysia)
- Maldives
- (Maldives)
- Mali
- (Mali)
- Mallorca
- (Mallorca)
- Malta
- (Malta)
- Marshall Islands
- (Marshall Islands)
- Martinique
- (Martinique)
- Mauritania
- (Mauritania)
- Mauritius
- (Mauritius)
- Mayotte
- (Mayotte)
- Mexico
- (Mexico)
- Micronesia
- (Micronesia)
- Moldova
- (Moldova)
- Monaco
- (Monaco)
- Mongolia
- (Mongolia)
- Montserrat
- (Montserrat)
- Morocco
- (Morocco)
- Mozambique
- (Mozambique)
- Myanmar
- (Myanmar)
- Namibia
- (Namibia)
- Nauru
- (Nauru)
- Nepal
- (Nepal)
- Netherlands
- (Netherlands)
- Netherlands Antilles
- (Netherlands Antilles)
- Neutral Zone (Saudia Arabia/Iraq)
- (Neutral Zone (Saudia Arabia/Iraq))
- New Caledonia
- (New Caledonia)
- New Zealand
- (New Zealand)
- Nicaragua
- (Nicaragua)
- Niger
- (Niger)
- Nigeria
- (Nigeria)
- Niue
- (Niue)
- Norfolk Island
- (Norfolk Island)
- Northern Ireland
- (Northern Ireland)
- Northern Mariana Islands
- (Northern Mariana Islands)
- Norway
- (Norway)
- Oman
- (Oman)
- Pakistan
- (Pakistan)
- Palau
- (Palau)
- Palestine
- (Palestine)
- Panama
- (Panama)
- Papua New Guinea
- (Papua New Guinea)
- Paraguay
- (Paraguay)
- Peru
- (Peru)
- Philippines
- (Philippines)
- Pitcairn
- (Pitcairn)
- Poland
- (Poland)
- Polynesia, French
- (Polynesia, French)
- Portugal
- (Portugal)
- Puerto Rico
- (Puerto Rico)
- Qatar
- (Qatar)
- Reunion
- (Reunion)
- Romania
- (Romania)
- Russia
- (Russia)
- Russian Federation
- (Russian Federation)
- Rwanda
- (Rwanda)
- S. Georgia and S. Sandwich Isls.
- (S. Georgia and S. Sandwich Isls.)
- Saint Kitts and Nevis
- (Saint Kitts and Nevis)
- Saint Lucia
- (Saint Lucia)
- Saint Vincent and The Grenadines
- (Saint Vincent and The Grenadines)
- Samoa
- (Samoa)
- San Marino
- (San Marino)
- Sao Tome and Principe
- (Sao Tome and Principe)
- Saudi Arabia
- (Saudi Arabia)
- Scotland
- (Scotland)
- Senegal
- (Senegal)
- Serbia
- (Serbia)
- Seychelles
- (Seychelles)
- Sierra Leone
- (Sierra Leone)
- Singapore
- (Singapore)
- Slovakia (Slovak Republic)
- (Slovakia (Slovak Republic))
- Slovenia
- (Slovenia)
- Solomon Islands
- (Solomon Islands)
- Somalia
- (Somalia)
- South Africa
- (South Africa)
- Southern Territories, French
- (Southern Territories, French)
- Soviet Union (former)
- (Soviet Union (former))
- Spain
- (Spain)
- Sri Lanka
- (Sri Lanka)
- St. Helena, Ascension and Tristan da
- Cunha
- (St. Helena, Ascension and Tristan da
- Cunha)
- St. Pierre and Miquelon
- (St. Pierre and Miquelon)
- Sudan
- (Sudan)
- Sudan, South
- (Sudan, South)
- Suriname
- (Suriname)
- Svalbard and Jan Mayen Islands
- (Svalbard and Jan Mayen Islands)
- Swaziland
- (Swaziland)
- Sweden
- (Sweden)
- Switzerland
- (Switzerland)
- Syria
- (Syria)
- Taiwan
- (Taiwan)
- Tajikistan
- (Tajikistan)
- Tanzania
- (Tanzania)
- Thailand
- (Thailand)
- Togo
- (Togo)
- Tokelau
- (Tokelau)
- Tonga
- (Tonga)
- Trinidad and Tobago
- (Trinidad and Tobago)
- Tunisia
- (Tunisia)
- Turkey
- (Turkey)
- Turkmenistan
- (Turkmenistan)
- Turks and Caicos Islands
- (Turks and Caicos Islands)
- Tuvalu
- (Tuvalu)
- Uganda
- (Uganda)
- Ukraine
- (Ukraine)
- United Arab Emirates
- (United Arab Emirates)
- United Kingdom (Great Britain)
- (United Kingdom (Great Britain))
- United States
- (United States)
- Uruguay
- (Uruguay)
- US Minor Outlying Islands
- (US Minor Outlying Islands)
- Uzbekistan
- (Uzbekistan)
- Vanuatu
- (Vanuatu)
- Vatican City State (Holy See)
- (Vatican City State (Holy See))
- Venezuela
- (Venezuela)
- Viet Nam
- (Viet Nam)
- Virgin Islands (British)
- (Virgin Islands (British))
- Virgin Islands (US)
- (Virgin Islands (US))
- Wales
- (Wales)
- Wallis and Futuna Islands
- (Wallis and Futuna Islands)
- Western Sahara
- (Western Sahara)
- Yemen
- (Yemen)
- Yugoslavia
- (Yugoslavia)
- Zaire
- (Zaire)
- Zambia
- (Zambia)
- Zimbabwe
- (Zimbabwe)
Population: population the individual (or ancestors) belongs to; e.g. white, gypsy, Jewish-Ashkenazi, Africa-N, Sardinia, etc.
Age at death: age at which the individual deceased (when applicable):
- 35y = 35 years
- >43y = still alive at 43y
- 04y08m = 4 years and 8 months
- 00y00m01d12h = 1 day and 12 hours
- 18y? = around 18 years
- 30y-40y = between 30 and 40 years
- >54y = older than 54
- ? = unknown
VIP: individual/phenotype VIP-status was requested for matchmaking - need collaboration(s) to crack the case - please contact the submitter/curator.
NOTE: to get VIP status ask the curator.
Data_av: are additional data available upon request: e.g. pedigree (yes/no/?)
Treatment: treatment of patient
Variants in genes: The individual has variants for this gene.
Panel size: Number of individuals this entry represents; e.g. 1 for an individual, 5 for a family with 5 affected members.

 Individual ID
|

 ID_report
|

 Reference
|
 Remarks
|

 Gender
|

 Consanguinity
|

 Country
|

 Population
|

 Age at death
|

 VIP
|

 Data_av
|

 Treatment
|

 Disease
|

 Phenotype details
|
 Genes screened
|
 Variants in genes
|

 Variants
|

 Panel size
|

 Owner
|
00000038 |
- |
PubMed: Bell 2011 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
- |
ALS2, ATP7B, CFTR, DPYD, GLB1, HEXB, MTHFR, MYO5A, NHLRC1, SMPD1 |
ALS2, ATP7B, CFTR, DPYD, GLB1, HEXB, MYO5A, NHLRC1, PRKAR1A, SMPD1, TMPPE |
9 |
1 |
Global Variome, with Curator vacancy |
00051661 |
- |
- |
- |
? |
- |
Japan |
- |
- |
- |
- |
- |
epilepsy |
epilepsy |
CYP2C9 |
CYP2C9 |
1 |
1 |
Johan den Dunnen |
00051662 |
- |
- |
- |
? |
- |
Japan |
- |
- |
- |
- |
- |
epilepsy |
epilepsy |
CYP2C9 |
CYP2C9 |
1 |
1 |
Johan den Dunnen |
00051663 |
- |
- |
- |
? |
- |
Japan |
- |
- |
- |
- |
- |
epilepsy |
epilepsy |
CYP2C9 |
CYP2C9 |
1 |
1 |
Johan den Dunnen |
00051664 |
- |
- |
- |
? |
- |
Japan |
- |
- |
- |
- |
- |
epilepsy |
epilepsy |
CYP2C9 |
CYP2C9 |
1 |
1 |
Johan den Dunnen |
00051665 |
- |
- |
- |
? |
- |
Japan |
- |
- |
- |
- |
- |
epilepsy |
epilepsy |
CYP2C9 |
CYP2C9 |
1 |
1 |
Johan den Dunnen |
00074462 |
- |
PubMed: Maljevic 2006, Journal: Maljevic 2006 |
- |
M |
no |
Germany |
white |
- |
- |
- |
- |
epilepsy |
18y old male patient with childhood absence epilepsy starting at age 3y. |
GABRA1 |
GABRA1 |
1 |
1 |
Bernt Popp |
00102728 |
24534542-Pat2 |
PubMed: Marques 2014 |
- |
M |
- |
Portugal |
- |
- |
- |
- |
- |
epilepsy, MRT |
Macrocephaly (1y); refractory epilepsy with progressive cognitive regression (6y); bilateral strabismus; with normal strength and without muscle complaints (able to run, climb stairs and run) at 21y; brain MRI: white matter changes and occypital agyria. |
LAMA2 |
LAMA2 |
2 |
1 |
Jorge Oliveira |
00119071 |
- |
- |
2-generation family, 3 affected (1F, 2M) |
F |
no |
- |
- |
- |
- |
- |
- |
epilepsy |
photosensitive genetic generalised epilepsy |
- |
HCN2 |
1 |
1 |
Christopher Reid |
00119072 |
- |
- |
2-generation family (2F, 1M) |
F |
no |
- |
- |
- |
- |
- |
- |
epilepsy |
Idiopathic Photosensitive Occipital Epilepsy |
- |
HCN2 |
1 |
1 |
Christopher Reid |
00119073 |
- |
- |
2-generation family, 2M affected, 1M variant carrier |
M |
no |
Italy |
- |
- |
- |
- |
- |
epilepsy |
early onset absence epilepsy |
- |
HCN2 |
1 |
1 |
Christopher Reid |
00119074 |
- |
- |
2-generation family, 3 affected |
F |
no |
- |
- |
- |
- |
- |
- |
epilepsy |
unclassified epilepsy |
- |
HCN2 |
1 |
3 |
Christopher Reid |
00119075 |
- |
- |
1M affected |
M |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
generalized epilepsy |
- |
HCN2 |
1 |
1 |
Christopher Reid |
00132052 |
- |
- |
- |
F |
- |
Germany |
- |
- |
- |
- |
- |
epilepsy |
Atypical absence seizures (HP:0007270), Generalized myoclonic seizures (HP:0002123) |
KCNMA1 |
KCNMA1 |
1 |
1 |
Qing Kenneth Wang |
00132053 |
- |
- |
- |
F |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
KCNMA1 |
KCNMA1 |
1 |
1 |
Qing Kenneth Wang |
00132054 |
- |
- |
- |
F |
- |
United States |
- |
- |
- |
- |
- |
epilepsy |
Absence seizures (HP:0002121), Atonic seizures (HP:0010819), Focal myoclonic seizures (HP:0011166), Focal tonic seizures (HP:0011167) |
KCNMA1 |
KCNMA1 |
1 |
1 |
Qing Kenneth Wang |
00132055 |
- |
- |
- |
F |
- |
Germany |
- |
- |
- |
- |
- |
epilepsy |
epileptic encephalopathy (HP:0200134) |
KCNMA1 |
KCNMA1 |
1 |
1 |
Qing Kenneth Wang |
00148581 |
- |
PubMed: Campion D 1995 PubMed: Campion D 1999 PubMed: Campion D 1995 |
- |
- |
- |
France |
white |
52y07m |
- |
- |
- |
AD, epilepsy |
- |
PSEN1 |
PSEN1 |
1 |
38 |
Marc Cruts |
00149037 |
- |
- |
- |
- |
- |
Greece |
white |
39y |
- |
- |
- |
AD, epilepsy |
- |
PSEN1 |
PSEN1 |
1 |
3 |
Marc Cruts |
00149438 |
- |
- |
- |
- |
- |
- |
white (Bulgarian) |
- |
- |
- |
- |
AD, epilepsy |
- |
PSEN1 |
PSEN1 |
1 |
2 |
Marc Cruts |
00149552 |
- |
- |
- |
- |
- |
- |
- |
67y |
- |
- |
- |
AD, epilepsy |
- |
APP |
APP |
1 |
2 |
Marc Cruts |
00154932 |
- |
- |
- |
F |
no |
Denmark |
- |
- |
- |
- |
- |
epilepsy, ID |
pregnancy uneventful; moderate intellectual disability (HP:0002342); moderate global developmental delay (HP:0011343); severe speech delay (HP:0000750) |
- |
CUX2 |
1 |
1 |
Elsebet Østergaard |
00163846 |
IV-1 |
PubMed: Pagnamenta 2018 |
DECIPHER ID 265247 |
M |
yes |
- |
Pakistani |
- |
- |
- |
- |
DD, epilepsy, microcephaly |
- |
- |
PIGH |
1 |
2 |
Philippe Campeau |
00163847 |
IV-2 |
PubMed: Pagnamenta 2018 |
- |
F |
yes |
- |
Pakistani |
- |
- |
- |
- |
DD, epilepsy, microcephaly |
- |
- |
PIGH |
1 |
1 |
Philippe Campeau |
00163931 |
259633 |
PubMed: Pagnamenta 2017 |
- |
F |
no |
- |
White British white |
- |
- |
- |
- |
epilepsy |
- |
- |
PIGN |
2 |
1 |
Philippe Campeau |
00163932 |
- |
PubMed: Nakagawa et al.2015 |
- |
M |
no |
Japan |
- |
- |
- |
- |
- |
epilepsy, ID |
- |
- |
PIGN |
2 |
1 |
Philippe Campeau |
00164481 |
R_1250 |
- |
- |
M |
no |
Poland |
- |
09y |
- |
- |
- |
epilepsy |
Epileptic encephalopathy (HP:0200134); Abnormal facial shape (HP:0001999) |
- |
PPP3CA |
1 |
1 |
Rafał Płoski |
00168053 |
15502825-Fam |
PubMed: Simpson 2004 |
8-generation family, 9 affected (2F, 7M), unaffected carrier parents/relatives |
F;M |
yes |
United States |
Amish |
- |
- |
- |
- |
epilepsy |
see paper; ..., infantile-onset
symptomatic epilepsy syndrome, developmental stagnation, blindness |
ST3GAL5 |
ST3GAL5 |
1 |
9 |
Johan den Dunnen |
00168065 |
22990144-FamPatV5/6 |
PubMed: Fragaki 2013 |
5-generation family, 2 affected brothers, unaffected heterozygous carrier parents/relatives |
M |
yes |
France |
- |
- |
- |
- |
- |
epilepsy |
see paper; ..., early-onset refractory epilepsy, psychomotor delay, failure to thrive, blindness, deafness |
ST3GAL5 |
ST3GAL5 |
1 |
2 |
Johan den Dunnen |
00180896 |
- |
PubMed: Zweier 2019, Journal: Zweier 2019 |
- |
M |
no |
United Kingdom (Great Britain) |
- |
- |
- |
- |
- |
epilepsy |
HP:0001249 |
- |
CYFIP2 |
1 |
1 |
Anaïs Begemann |
00205855 |
- |
- |
- |
- |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
CAMK2A |
- |
- |
1 |
Jinliang Li |
00205859 |
- |
- |
- |
- |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
- |
SCN3A |
1 |
1 |
Jinliang Li |
00205861 |
patient 1 |
- |
- |
F |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
HDAC8 |
HDAC8 |
1 |
1 |
Jinliang Li |
00205862 |
patient2 |
- |
- |
F |
no |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
CAMK2A |
CAMK2A |
1 |
1 |
Jinliang Li |
00205864 |
patient3 |
- |
- |
F |
no |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
HIBCH |
HIBCH |
2 |
1 |
Jinliang Li |
00205865 |
patient4 |
- |
- |
F |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
KCNQ5 |
KCNQ5 |
1 |
1 |
Jinliang Li |
00205866 |
patient5 |
- |
- |
M |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
KCNQ5 |
KCNQ5 |
1 |
1 |
Jinliang Li |
00205867 |
patient6 |
- |
- |
M |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
SCN3A |
SCN3A |
1 |
1 |
Jinliang Li |
00205868 |
patient7 |
- |
- |
F |
no |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
PPP3CA |
PPP3CA |
1 |
1 |
Jinliang Li |
00205869 |
patient8 |
- |
- |
F |
no |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
PACS2 |
PACS2 |
1 |
1 |
Jinliang Li |
00207532 |
Patient |
PubMed: Foskett et al., 2018 |
- |
F |
no |
Mexico |
Mexican |
>00y08m |
- |
- |
- |
epilepsy |
Infantile spasms, myoclonic seizures, cortical visual impairment, developmental delay, and minor dysmorphic features (Anteverted nares, tented upper lip), pectus excavatum, and mild flexion contractures of all fingers bilaterally. Alkaline phosphatase levels ranged from normal to mildly elevated. No evidence of metabolic bone disease. |
PIGW |
PIGW |
2 |
1 |
Philippe Campeau |
00209022 |
28771251-Pat37 |
PubMed: Lionel 2018 |
- |
M |
- |
Canada |
- |
- |
- |
- |
- |
epilepsy |
epilepsy |
GRIN2A |
GRIN2A |
1 |
1 |
Johan den Dunnen |
00209024 |
28771251-Pat41 |
PubMed: Lionel 2018 |
- |
M |
- |
Canada |
- |
- |
- |
- |
- |
epilepsy |
Epilepsy and global developmental delay |
STXBP1 |
STXBP1 |
1 |
1 |
Johan den Dunnen |
00218061 |
- |
III.3 |
- |
F |
no |
Poland |
- |
- |
- |
- |
- |
epilepsy |
Generalised epilepsy
Intellectual Disability
Gingival Abnormalities
Nail Abnormalities |
ATP6V1B2 |
ATP6V1B2 |
1 |
6 |
Marie Shaw |
00224853 |
- |
unpublished |
- |
M |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
- |
TSC1 |
TSC1 |
1 |
1 |
Rosemary Ekong |
00226156 |
- |
- |
- |
- |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
CSNK2B |
CSNK2B |
1 |
1 |
Jinliang Li |
00226157 |
- |
- |
- |
- |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
CSNK2B |
CSNK2B |
1 |
1 |
Jinliang Li |
00226158 |
- |
- |
- |
- |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
CSNK2B |
CSNK2B |
1 |
1 |
Jinliang Li |
00226159 |
- |
- |
- |
- |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
CSNK2B |
CSNK2B |
1 |
1 |
Jinliang Li |
00226160 |
- |
- |
- |
- |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
CSNK2B |
CSNK2B |
1 |
1 |
Jinliang Li |
00226161 |
- |
- |
- |
- |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
CSNK2B |
CSNK2B |
1 |
1 |
Jinliang Li |
00226162 |
- |
- |
- |
- |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
- |
CSNK2B |
1 |
1 |
Jinliang Li |
00226163 |
- |
- |
- |
- |
- |
China |
- |
- |
- |
- |
- |
epilepsy |
- |
CSNK2B |
CSNK2B |
1 |
1 |
Jinliang Li |
00239139 |
- |
- |
- |
F |
- |
China |
Chinese |
00y04m |
- |
- |
- |
epilepsy |
Infantile spasms (HP:0012469); Neurodevelopmental delay (HP:0012758); |
HECW2 |
HECW2 |
1 |
1 |
Mengna Zhang |
00239140 |
- |
- |
- |
F |
no |
China |
Chinese |
00y10m |
- |
- |
- |
epilepsy |
infantile spasms(HP:0012469), Neurodevelopmental delay (HP:0012758), Muscular hypotonia (HP:0001252),Intrauterine growth retardation (HP:0001511) |
HECW2 |
HECW2 |
1 |
1 |
Mengna Zhang |
00239190 |
case |
PubMed: Moore 2001 |
- |
F |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
5y-typical childhood absence epilepsy; 14-15y developed myoclonic seizures and later rare tonic-clonic seizures; EEG typical absences and subsequent persistent bilateral synchronous spike-wave discharges without accompanying clinical signs, last 20 years the EEG normal |
JRK |
JRK |
1 |
1 |
Johan den Dunnen |
00239790 |
- |
- |
- |
M |
- |
Argentina |
- |
- |
- |
- |
- |
epilepsy |
persistent crisis of atipical febrile seizures |
SCN1A |
ALDH7A1, SCN1A |
2 |
1 |
GENBIOMOL - Carla Bidinost |
00265870 |
- |
PubMed: Nakashima 2020 |
- |
F |
no |
Japan |
- |
- |
- |
- |
- |
epilepsy |
Epileptic spasms |
- |
CUL3 |
1 |
1 |
Mitsuko Nakashima |
00265878 |
- |
PubMed: Nakashima 2020 |
- |
M |
no |
Malaysia |
- |
- |
- |
- |
- |
epilepsy |
Epileptic spasms |
- |
CUL3 |
1 |
1 |
Mitsuko Nakashima |
00266658 |
- |
- |
- |
M |
- |
(Italy) |
- |
- |
- |
- |
- |
epilepsy |
Early severe epileptic encephalopathy, spastic tetraplegia, opisthotonos attacks |
KCNC2 |
KCNC2 |
1 |
1 |
Maurizio Elia |
00269544 |
- |
PubMed: Baulac 2001 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
generalized epilepsy with febrile seizures plus |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269545 |
- |
PubMed: Shi 2010 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
seizures, generalized tonic-clonic |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269546 |
- |
PubMed: Cantarín-Extremera 2011 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
generalized epilepsy with febrile seizures plus |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269547 |
- |
PubMed: Hirose 2006 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
myoclonic epilepsy of infancy |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269548 |
- |
Johnston 2010, HG online |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
generalized epilepsy with febrile seizures plus |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269549 |
- |
PubMed: Wallace 2001 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
epilepsy, childhood absence with febrile seizures |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269550 |
- |
PubMed: Cantarín-Extremera 2011 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
generalized epilepsy with febrile seizures plus |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269551 |
- |
PubMed: Lachance-Touchette 2011 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
epilepsy, idiopathic generalised |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269552 |
- |
PubMed: Harkin 2002 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
generalized epilepsy with febrile seizures plus |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269553 |
- |
PubMed: Audenaert 2006 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
febrile seizures |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269554 |
- |
PubMed: Sun 2008 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
generalized epilepsy with febrile seizures plus |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00269555 |
- |
PubMed: Kananura 2002 |
- |
- |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
epilepsy, childhood absence with febrile seizures |
GABRG2 |
GABRG2 |
1 |
1 |
Johan den Dunnen |
00270541 |
105297 |
- |
- |
M |
? |
Germany |
- |
- |
- |
- |
- |
epilepsy, stroke, ischemic, susceptibility to |
HPOs: Tinnitus; Nausea; Gait ataxia; Vertigo; Vestibular nystagmus, Seizures; Intracranial hemorrhage |
KCNH2 |
KCNH2 |
1 |
1 |
Andreas Laner |
00270548 |
108406 |
- |
- |
F |
- |
Germany |
- |
- |
- |
- |
- |
epilepsy |
HPOs: Abnormality of the nervous system; Epileptic encephalopathy |
SCN5A |
SCN5A |
1 |
1 |
Andreas Laner |
00271176 |
108406 |
- |
- |
F |
? |
Germany |
- |
- |
- |
- |
- |
epilepsy |
HPO: Abnormality of the nervous system; Epileptic encephalopathy |
SCN5A |
SCN5A |
1 |
1 |
Andreas Laner |
00274290 |
- |
PubMed: Wayhelova 2020, Journal: Wayhelova 2020 |
2-generation family, 2 affected, unaffected carrier mother |
M |
no |
Czech Republic |
white |
>09y |
- |
- |
antiepileptic drug therapy |
epilepsy |
biotinidase deficiency, intellectual disability, developmental delay, autistic features, cortical blindness, intractable atonic seizures |
- |
BTD, IQSEC2 |
2 |
2 |
Marketa Wayhelova |
00274291 |
brother |
PubMed: Wayhelova 2020, Journal: Wayhelova 2020 |
brother of 00274290 |
M |
no |
Czech Republic |
white |
>02y |
- |
- |
antiepileptic drug therapy |
epilepsy |
biotinidase deficiency not related to epilepsy and neurodevelopmental disorders, intractable seizures, developmental delay, central hypotonia
biotinidase deficiency not related to neurodevelopmental disorders |
- |
BTD, IQSEC2 |
2 |
1 |
Marketa Wayhelova |
00279047 |
- |
PubMed: Ekong, 2016 |
patient examined and does not have any clinical or radiographic findings to support a diagnosis of TSC; variant identified in infantile epilepsy panel test and reported as pathogenic by the diagnostic lab; 2 half siblings tested and variant not found; parents not tested; we cannot exclude the possibility that the variant contributes to the patient's phenotype |
M |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
epilepsy and intellectual disability |
TSC2 |
TSC2 |
1 |
1 |
Rosemary Ekong |
00279516 |
- |
unpublished |
- |
M |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
- |
TSC2 |
TSC2 |
1 |
1 |
Rosemary Ekong |
00281095 |
- |
unpublished |
infant with multiple seizures; one of the parents with seizures was tested and also has the same variant |
? |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
seizures |
TSC2 |
TSC2 |
1 |
2 |
Rosemary Ekong |
00281298 |
- |
unpublished |
patient reported to have some irregular hypopigmentation that are not typical hypopigmented macules; MRI of brain normal; no FH of seizures or TSC |
M |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
seizures |
TSC2 |
TSC2 |
1 |
1 |
Rosemary Ekong |
00281299 |
- |
unpublished |
patient has seizures and a reported likely pathogenic variant in SCN2A (not specified); TSC2 c.1244C>T also seen in one parent who is apparently asymptomatic |
F |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
seizures |
TSC2 |
TSC2 |
1 |
2 |
Rosemary Ekong |
00281300 |
- |
unpublished |
patient has seizures and developmental delay; no family information |
? |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
seizures, developmental delay |
TSC2 |
TSC2 |
1 |
1 |
Rosemary Ekong |
00281357 |
- |
unpublished |
parents not tested |
M |
- |
- |
- |
- |
- |
- |
- |
epilepsy |
- |
TSC2 |
TSC2 |
1 |
1 |
Rosemary Ekong |
00289331 |
FamPatII2 |
PubMed: Muona 2016 |
2-generation family, 1 affected (F), unaffected heterozygous carrier parents |
F |
- |
Finland |
- |
- |
- |
- |
- |
epilepsy |
see paper; ..., rapidly progressing cerebral atrophy, intractable seizures, and intellectual disability |
ADAM22 |
ADAM22 |
2 |
1 |
Johan den Dunnen |
00295737 |
109812 |
- |
- |
M |
yes |
Turkey |
- |
- |
- |
- |
- |
autism, DD, epilepsy |
Autism, Intellectual disability, Generalized-onset seizure |
EZR |
EZR |
1 |
1 |
Andreas Laner |
00295764 |
- |
- |
- |
M |
yes |
Morocco |
- |
- |
- |
- |
- |
epilepsy |
epileptic spasms
right frontal seizure
truncal hypotonia |
PDE2A |
PDE2A |
1 |
1 |
Gabrielle Rudolf |
00296271 |
Fam1PatII1 |
PubMed: Hamanaka 2020, Journal: Hamanaka 2020 |
2-generation family, 1 affected, unaffected non-carrier parents |
M |
- |
Japan |
- |
- |
- |
- |
- |
epilepsy |
rolling over-12m,; meaningful words 24-36m; seizure, developmental delay; walk-1y5m; severe intellectual disability (IQ=25 17y); speech few words; no microcephaly; 6y-generalized tonic-clonic seizures, 9y-absence seizure, 11y-atonic seizure; seizure therapy intractable; regression motor skill and dysarthria; ataxia; intention tremor; rigidity; myoclonus; spasticity; increased deep tendon reflex upper and lower limbs; pathogenic reflex Rossolimo sign positive, Mendel-Bechterew sign positive; no dysmorphic features; wheelchair-bound; MRI brain normal; EEG abnormal discharge in right hemisphere (6 years), burst of diffuse irregular spikes and slow waves (9 years), diffuse spike and slow waves in frontal, parietal and temporal regions (14 years); somatosensory evoked potential prolonged N20 latency and high amplitude of P24-N33 |
SEMA6B |
SEMA6B |
1 |
1 |
Johan den Dunnen |
00296272 |
Fam2PatII1 |
PubMed: Hamanaka 2020, Journal: Hamanaka 2020 |
2-generation family, 1 affected, unaffected non-carrier parents |
F |
- |
Japan |
- |
- |
- |
- |
- |
epilepsy |
walking without support-28m; seizure; walk-2y4m; severe intellectual disability (IQ=25 12y); speech few words; microcephaly (−2.0 SD); 11m-generalized tonic-clonic seizures, 5y-loss of consciousness with abnormal eye movement, 10y-complex partial seizure, 10y-atonic seizure,; seizure therapy intractable; regression motor skill; ataxia; intention tremor; rigidity; myoclonus; spasticity; increased deep tendon reflex upper and lower limbs; no pathogenic reflex; no dysmorphic features; wheelchair-bound; MRI brain mild cerebellar atrophy; EEG diffuse slow wave with 2–3 Hz and spike-and-wave in bilateral frontal region (3 years and 4 years), diffuse theta waves with 4–5 Hz and spike-and-wave burst with 2–3 Hz (9 years), multifocal spikes in left parietal region and bilateral frontal regions (12 years), multispikes in left occipital region (13 years), slow waves at baselines (23 years); giant somatosensory evoked potential; systemic lupus erythematosus |
SEMA6B |
SEMA6B |
1 |
1 |
Johan den Dunnen |
00296273 |
Fam3PatII4 |
PubMed: Hamanaka 2020, Journal: Hamanaka 2020 |
2-generation family, 1 affected, unaffected non-carrier parents |
M |
- |
Israel |
- |
- |
- |
- |
- |
epilepsy |
walking without support-24m; seizure; walk-2y; severe intellectual disability; no speech; microcephaly (−2.5 SD); 2y-absence seizure ; seizure therapy responsive; regression motor and verbal skills; ataxia; intention tremor; no dysmorphic features; wheelchair-bound; MRI brain small vermis; EEG abnormal background activity (1 year), slow abnormal sleep features with paucity of sleep spindles (13 years) |
SEMA6B |
SEMA6B |
1 |
1 |
Johan den Dunnen |
00296274 |
Fam4PatII4 |
PubMed: Hamanaka 2020, Journal: Hamanaka 2020 |
2-generation family, 1 affected, unaffected non-carrier parents |
F |
- |
Malaysia |
- |
- |
- |
- |
- |
epilepsy |
eye pursuit-5m, walking without support-24m, meaningful words-30m; seizure and developmental delay; walk-2y; severe intellectual disability; speech few words; microcephaly (2nd percentile); 4y-atonic seizure; seizure therapy intractable, but improved by clobazam and sulthiame (responsive); regression; ataxia; intention tremor; myoclonus; no increased deep tendon reflex; no pathogenic reflex; no dysmorphic features; walking with support; MRI brain normal; EEG focal bifrontal epileptiform discharges accentuated during sleep (4 years), frequent frontocentral discharges during awake state (5 years), frequent intermittent slow spikes in right posterior region (11 years) |
SEMA6B |
SEMA6B |
1 |
1 |
Johan den Dunnen |
00303557 |
Fam1Pat1 |
PubMed: Manole 2020 |
2-generation family, 1 affected, unaffected non-carrier parents |
F |
no |
Netherlands |
- |
- |
- |
- |
- |
epilepsy |
see paper; ..., microcephaly; global developmental delay; 18m-sit; 3y-walk; language severely delayed; severe intellectual disability; generalised tonic clonic seizures; peripheral neuropathy; ataxia; imaging no anomalies detected; upslanting palpebral fissures, pes-cavus; tone normal; power reduced; ataxic gait; reflexes reduced |
NARS |
NARS |
1 |
1 |
Stephanie Efthymiou |
00303558 |
Fam7Pat7 |
PubMed: Manole 2020 |
2-generation family, 1 affected, unaffected non-carrier parents |
F |
no |
United Kingdom (Great Britain) |
- |
- |
- |
- |
- |
epilepsy |
see paper; ..., no microcephaly; global developmental delay; 12m-sit; 2y3m-walk; language severely delayed; severe intellectual disability; generalised tonic clonic seizures; large ears, long slender fingers; tone reduced; reflexes increased |
NARS |
NARS |
1 |
1 |
Stephanie Efthymiou |
00303559 |
Fam8Pat8 |
PubMed: Manole 2020 |
2-generation family, 1 affected, unaffected non-carrier parents |
M |
no |
United States |
Germany-Ireland;England-native American;Russia-Poland |
- |
- |
- |
- |
epilepsy |
see paper; ..., microcephaly; global developmental delay; 8m-sit; 2y11m-walk; language severely delayed; severe intellectual disability; myoclonic/partial seizures; ataxia; imaging no anomalies detected; broad forehead; tone increased; normal power; ataxic gait; reflexes increased; stereotypies |
NARS |
NARS |
1 |
1 |
Stephanie Efthymiou |
00303561 |
Fam16Pat24 |
PubMed: Manole 2020 |
2-generation family, affected sister/brother, unaffected heterozygous parents |
M |
no |
Kosovo |
- |
- |
- |
- |
- |
epilepsy |
see paper; ..., microcephaly; global developmental delay; not sitting; not waking; language notdelayed; profound intellectual disability; myoclonic/generalised tonic clonic seizures; delayed myelination; no dysmorphic features; tone increased; power reduced; reflexes reduced |
NARS |
NARS |
1 |
2 |
Stephanie Efthymiou |
00303562 |
Fam17Pat26 |
PubMed: Manole 2020 |
4-generation family, 3 affected sibs (2F, M), unaffected heterozygous parents |
F |
yes |
Libya |
- |
- |
- |
- |
- |
epilepsy |
see paper; ..., microcephaly; global developmental delay; language severely delayed; severe intellectual disability; generalised tonic clonic seizures; |
NARS |
NARS |
1 |
3 |
Stephanie Efthymiou |
00303563 |
Fam18Pat27 |
PubMed: Manole 2020 |
2-generation family, affected sisters, unaffected heterozygous parents |
F |
no |
Germany |
- |
- |
- |
- |
- |
epilepsy |
see paper; ..., microcephaly; global developmental delay; 3y-walk; language severely delayed; severe intellectual disability; generalised tonic clonic seizures; peripheral neuropathy; ataxia; imaging no anomalies detected; no dysmorphic features; tone reduced; power reduced; sensation reduced; ataxic gait; reflexes reduced |
NARS |
NARS |
2 |
2 |
Stephanie Efthymiou |
00303564 |
Fam19Pat29 |
PubMed: Manole 2020 |
3-generation family, affected brother/sister, unaffected heterozygous parents |
M |
no |
Turkey |
- |
- |
- |
- |
- |
epilepsy |
see paper; ..., microcephaly; global developmental delay; 3y-walk; language severely delayed; severe intellectual disability; generalised tonic clonic seizures; thickening of gyri; no dysmorphic features |
NARS |
NARS |
2 |
2 |
Stephanie Efthymiou |
00303565 |
Fam20Pat31 |
PubMed: Manole 2020 |
2-generation family, 1 affected, unaffected heterozygous parents |
F |
no |
Canada |
- |
- |
- |
- |
- |
epilepsy |
see paper; ..., microcephaly; global developmental delay; 6y10m-walk; language severely delayed; severe intellectual disability; generalised tonic clonic seizures; ataxia; thin corpus callosum, decreased white matter; hypotelorism; tone reduced; normal power; sensation normal; ataxic gait; reflexes normal; hip dysplasia |
NARS |
NARS |
2 |
1 |
Stephanie Efthymiou |
00303566 |
Fam21Pat32 |
PubMed: Manole 2020 |
2-generation family, 1 affected, unaffected heterozygous parents |
M |
no |
United States |
- |
- |
- |
- |
- |
epilepsy |
see paper; ..., microcephaly; global developmental delay; 10m-sit; 3y-walk; language severely delayed; severe intellectual disability; generalised tonic clonic seizures; ataxia; arachnoid cyst; no dysmorphic features; tone increased; normal power; sensation normal; ataxic gait; reflexes increased |
NARS |
NARS |
2 |
1 |
Stephanie Efthymiou |